Abstract:Background: Acute myeloid leukemia (AML) originates in the bone marrow, evading immune recognition and destruction. The bone marrow microenvironment (BME), comprising diverse immune cells and regulators, profoundly influences AML development. However, the impact of immune regulators in the BME, particularly on T-cell anti-AML immunity, remains inadequately understood. Therefore, evaluating the impact of immune regulators in the AML bone marrow microenvironment on T cell dysfunction is of paramount importance and necessity. M ethod : Bone marrow blood samples were obtained from pediatric AML patients at diagnosis and age-matched healthy individuals considered as hematopoietic stem cell transplantation (HSCT) donors after written informed consent. By centrifuging at 2000-3000rpm for 10min, we obtained the supernatant as plasma and stored it in a -80°C refrigerator. After using proteomics to identify the expression of 180 immune regulatory factors in plasma samples, we performed GO and KEGG functional enrichment analysis. After density gradient centrifugation, we isolated bone marrow mononuclear cells (BMMNCs) and immediately identified frequencies of T cell populations and expression levels of functional markers by flow cytometry when they were fresh. Moreover, the co-culture model of CD8 +T cells and THP-1 cell line was used to evaluate the anti-AML effector function of T cells. CD8 +T cells in BMMNCs were sorted by FACS and then subjected to whole transcriptome sequencing and in vitro experiments. After using the TRRUST and KnockTF databases for transcription factor prediction analysis, we selected phospho-flow cytometry to detect and verify the association between the level of phosphorylation of transcription factors and the function of CD8 +T cells. The data were analyzed using R software. Results: Using proteomics techniques, we uncovered a substantial presence of immune-suppressive regulatory factors in AML bone marrow plasma. Interestingly, the canonical NF-κB pathway, mediated by immune regulators and vital for immune regulation in BME, displayed significant downregulation, implying T-cell dysfunction. In our investigation, we identified dysfunctional CD8 +T cells in the primary AML bone marrow, characterized by heightened expression of co-inhibitory receptors and pro-dysfunctional transcription factors, as well as significantly decreased anti-AML effector function. Transcriptome sequencing further linked AML CD8 +T cell dysfunction to reduced transcriptional activity of NF-κB p65 in the canonical NF-κB signaling pathway. Intriguingly, in vitro inhibition of NF-κB p65 and its phosphorylation led to elevated expression of exhaustion markers, such as PD-1, LAG-3, and TIM-3 on primary CD8 +T cells. Most notably, the stimulation of the canonical NF-κB signaling pathway effectively restored activation and effector function-related pathways in dysfunctional AML CD8 +T cells. Conclusion: Immune regulators in the bone marrow microenvironment play a vital role in maintaining dysfunctional AML CD8 +T cells. These findings provide a novel strategy to investigate the potential mechanisms and interventions for T-cell dysfunction.

Increased TOX Expression Concurrent with PD-1, Tim-3, and CD244 Expression in T Cells from Patients with Acute Myeloid Leukemia.

Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia

Increased TOX Expression Associates with Exhausted T Cells in Patients with Multiple Myeloma

Higher Tim-3 expression concurrent with PD-1 in exhausted CD4+ and CD8+T cells in patients with acute myeloid leukemia

Increased TOX Expression Concurrent with PD-1, Tim-3, and CD244 in T Cells from Patients with Non-Hodgkin Lymphoma.

Increased PD-1+Tim-3+ Exhausted T Cells in Bone Marrow May Influence the Clinical Outcome of Patients with AML.

Higher TOX Genes Expression is Associated with Poor Overall Survival for Patients with Acute Myeloid Leukemia.

Higher Frequency of the CTLA‐4+LAG‐3+ T‐cell Subset in Patients with Newly Diagnosed Acute Myeloid Leukemia

Characteristics of PD-1, TIM-3 Expression and Exhausted Phenotype in T Cells from Peripheral Blood and Bone Marrow in Patients with AML

Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia.

Increasing Frequency of T Cell Immunosuppressive Receptor Expression in Cd4+And Cd8+T Cells May Related to T Cell Exhaustion and Immunosuppression in Patients with Aml

Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia

Inhibition of TOX exerts anti-tumor effects in acute myeloid leukemia by upregulating IRF7 expression

Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8+ cytolytic T cells

Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy

High Tim-3 expression on AML blasts could enhance chemotherapy sensitivity.

Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer

Dysregulation of Immune Regulators in AML Bone Marrow Promotes Dysfunction of CD8 + T Cells

Increasing Tim‐3+CD244+, Tim‐3+CD57+, and Tim‐3+PD‐1+ T Cells in Patients with Acute Myeloid Leukemia

Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia

Increased PD-1(+)Foxp3(+) gamma delta T cells associate with poor overall survival for patients with acute myeloid leukemia